Skip to content

Organon OGN Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
AbbVie logo
AbbVieABBV
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
PBH
Prestige Consumer HealthcarePBH
Viatris logo
ViatrisVTRS
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's common stock, shares issued (in shares)?
Organon (OGN) reported common stock, shares issued (in shares) of $262.65M in Q1 2026.
How has Organon's common stock, shares issued (in shares) changed year-over-year?
Organon's common stock, shares issued (in shares) increased by 1.8% year-over-year, from $257.95M to $262.65M.
What is the long-term trend for Organon's common stock, shares issued (in shares)?
Over 4 years (2021 to 2025), Organon's common stock, shares issued (in shares) has grown at a 0.7% compound annual growth rate (CAGR), from $253.55M to $260.32M.